Trial Profile
Study of the efficacy and safety of tadalafil and imidafenacin combination therapy for benign prostatic hyperplasia with overactive bladder
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2017
Price :
$35
*
At a glance
- Drugs Imidafenacin (Primary) ; Tadalafil
- Indications Benign prostatic hyperplasia; Overactive bladder
- Focus Therapeutic Use
- 15 Mar 2017 Status changed from recruiting to completed.
- 16 May 2016 New trial record